These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Is it safe to use anti-TNF-α agents for tuberculosis in children suffering with chronic rheumatic disease? Kilic O; Kasapcopur O; Camcioglu Y; Cokugras H; Arisoy N; Akcakaya N Rheumatol Int; 2012 Sep; 32(9):2675-9. PubMed ID: 21789614 [TBL] [Abstract][Full Text] [Related]
6. Adalimumab in the therapy of uveitis in childhood. Biester S; Deuter C; Michels H; Haefner R; Kuemmerle-Deschner J; Doycheva D; Zierhut M Br J Ophthalmol; 2007 Mar; 91(3):319-24. PubMed ID: 17035274 [TBL] [Abstract][Full Text] [Related]
7. Tumor necrosis factor inhibitors in the management of juvenile idiopathic arthritis: an evidence-based review. Shenoi S; Wallace CA Paediatr Drugs; 2010 Dec; 12(6):367-77. PubMed ID: 21028916 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of adalimumab in young children with juvenile idiopathic arthritis and chronic uveitis: a case series. La Torre F; Cattalini M; Teruzzi B; Meini A; Moramarco F; Iannone F BMC Res Notes; 2014 May; 7():316. PubMed ID: 24886032 [TBL] [Abstract][Full Text] [Related]
9. Clinical and economic burden of extra-articular manifestations in ankylosing spondylitis patients treated with anti-tumor necrosis factor agents. Gao X; Wendling D; Botteman MF; Carter JA; Rao S; Cifaldi M J Med Econ; 2012; 15(6):1054-63. PubMed ID: 22563743 [TBL] [Abstract][Full Text] [Related]
10. Comparing the risk of developing uveitis in patients initiating anti-tumor necrosis factor therapy for ankylosing spondylitis: an analysis of a large US claims database. Wendling D; Joshi A; Reilly P; Jalundhwala YJ; Mittal M; Bao Y Curr Med Res Opin; 2014 Dec; 30(12):2515-21. PubMed ID: 25252590 [TBL] [Abstract][Full Text] [Related]
11. Use of adalimumab in patients with juvenile idiopathic arthritis refractory to etanercept and/or infliximab. Katsicas MM; Russo RA Clin Rheumatol; 2009 Aug; 28(8):985-8. PubMed ID: 19322622 [TBL] [Abstract][Full Text] [Related]
12. A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness. Chen YF; Jobanputra P; Barton P; Jowett S; Bryan S; Clark W; Fry-Smith A; Burls A Health Technol Assess; 2006 Nov; 10(42):iii-iv, xi-xiii, 1-229. PubMed ID: 17049139 [TBL] [Abstract][Full Text] [Related]
13. [Research update of anti-TNF-α biologic agents in the treatment of uveitis]. Fan F; Zhou M; Luo Y Zhonghua Yan Ke Za Zhi; 2013 Mar; 49(3):285-8. PubMed ID: 23866712 [TBL] [Abstract][Full Text] [Related]
14. [Anti-TNF-α in the treatment of uveitis in the Besançon Hospital]. Fery-Blanco C; Schwartz C; Gil H; Curlier E; Prati C; Delbosc B J Fr Ophtalmol; 2011 Dec; 34(10):697-702. PubMed ID: 21889230 [TBL] [Abstract][Full Text] [Related]
15. Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systematic review and economic evaluation. McLeod C; Bagust A; Boland A; Dagenais P; Dickson R; Dundar Y; Hill RA; Jones A; Mujica Mota R; Walley T Health Technol Assess; 2007 Aug; 11(28):1-158, iii-iv. PubMed ID: 17651658 [TBL] [Abstract][Full Text] [Related]
16. Juvenile idiopathic arthritis: current and future treatment options. Martini G; Zulian F Expert Opin Pharmacother; 2006 Mar; 7(4):387-99. PubMed ID: 16503811 [TBL] [Abstract][Full Text] [Related]
17. Infliximab and etanercept in the treatment of chronic uveitis associated with refractory juvenile idiopathic arthritis. Tynjälä P; Lindahl P; Honkanen V; Lahdenne P; Kotaniemi K Ann Rheum Dis; 2007 Apr; 66(4):548-50. PubMed ID: 17068061 [TBL] [Abstract][Full Text] [Related]
18. Tumour necrosis factor alpha inhibitors in the treatment of childhood uveitis. Saurenmann RK; Levin AV; Rose JB; Parker S; Rabinovitch T; Tyrrell PN; Feldman BM; Laxer RM; Schneider R; Silverman ED Rheumatology (Oxford); 2006 Aug; 45(8):982-9. PubMed ID: 16461435 [TBL] [Abstract][Full Text] [Related]
19. Management of severe psoriasis with TNF antagonists. Adalimumab, etanercept and infliximab. Mössner R; Reich K Curr Probl Dermatol; 2009; 38():107-136. PubMed ID: 19710553 [TBL] [Abstract][Full Text] [Related]
20. [Importance of the new biologicals and cytokine antagonists in the treatment of juvenile idiopathic arthritis (JIA)]. Horneff G Z Rheumatol; 2005 Jun; 64(5):317-26. PubMed ID: 15965816 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]